Lentiviral gene therapy for X-linked chronic granulomatous disease

Kohn, D. B., Booth, C., Kang, E. M., Pai, S., Shaw, K. L., Santilli, G., Armant, M., Buckland, K. F., Choi, U., De Ravin, S. S., Dorsey, M. J., Kuo, C. Y., Leon-Rico, D., Rivat, C., Izotova, N., Gilmour, K., Snell, K., Dip, J. X., Darwish, J., Morris, E. C., Terrazas, D., Wang, L. D., Bauser, C. A., Paprotka, T., Kuhns, D. B., Gregg, J., Raymond, H. E., Everett, J. K., Honnet, G., Biasco, L., Newburger, P. E., Bushman, F. D., Grez, M., Gaspar, H. B., Williams, D. A., Malech, H. L., Galy, A., Thrasher, A. J.  Lentiviral gene therapy for X-linked chronic granulomatous disease.  Nature Medicine. 2020; 26(2), 200-206.  doi: 10.1038/s41591-019-0735-5

Date

BioLife Solutions Symbol

This website uses cookies to ensure you get the best experience on our website.